{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:56:58Z","timestamp":1791215818225,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T00:00:00Z","timestamp":1190160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Ethics"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1186\/1472-6939-8-10","type":"journal-article","created":{"date-parts":[[2007,9,19]],"date-time":"2007-09-19T02:12:56Z","timestamp":1190167976000},"source":"Crossref","is-referenced-by-count":23,"title":["Microbicide research in developing countries: have we given the ethical concerns due consideration?"],"prefix":"10.1186","volume":"8","author":[{"given":"Keymanthri","family":"Moodley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,19]]},"reference":[{"key":"58_CR1","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJM199709183371209","volume":"337","author":"M Angell","year":"1997","unstructured":"Angell M: The ethics of clinical research in the third world. N Engl J Med. 1997, 337: 847-9. 10.1056\/NEJM199709183371209.","journal-title":"N Engl J Med"},{"key":"58_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1126\/science.279.5348.186","volume":"279","author":"BR Bloom","year":"1998","unstructured":"Bloom BR: The Highest Attainable Standard: Ethical Issues in AIDS Vaccines. Science. 1998, 279: 186-188. 10.1126\/science.279.5348.186.","journal-title":"Science"},{"key":"58_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1076\/jmep.27.2.197.2986","volume":"27","author":"K Moodley","year":"2002","unstructured":"Moodley K: HIV Vaccine Trial Participation in South Africa: An ethical assessment. J Med & Phil. 2002, 27: 197-215. 10.1076\/jmep.27.2.197.2986.","journal-title":"J Med & Phil"},{"key":"58_CR4","volume-title":"Ethical Considerations in HIV Preventive Vaccine Research","author":"UNAIDS","year":"2002","unstructured":"UNAIDS: Ethical Considerations in HIV Preventive Vaccine Research. 2002"},{"key":"58_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJM199808203390803","volume":"339","author":"RE Roddy","year":"1998","unstructured":"Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL: A Conntrolled Trial of Nonoxynol 9 Film to Reduce Male-to-female Transmission of Sexually Transmitted Diseases. N Eng J Med. 1998, 339: 504-510. 10.1056\/NEJM199808203390803.","journal-title":"N Eng J Med"},{"key":"58_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/S0140-6736(02)11079-8","volume":"360","author":"L Van Damme","year":"1492","unstructured":"Van Damme L, Ramjee G, Alary M, Vuylsteke , Chandeying V, Rees H, Sirivongrangson P, Mukenge-Tshibaka L, Ettiegne-Traore V, Uaheowitchai C, Abdool Karrim SS, Masse B, Perriens J, Laga M: Effectiveness of COL- a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomized controlled trial. The Lancet. 1492, 360: 971-977. 10.1016\/S0140-6736(02)11079-8.","journal-title":"The Lancet"},{"key":"58_CR7","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1473-3099(07)70039-7","volume":"7","author":"J Horwood","year":"2007","unstructured":"Horwood J: Cellulose sulphate microbicide trial halted. The Lancet Infectious Diseases. 2007, 7: 183-10.1016\/S1473-3099(07)70039-7.","journal-title":"The Lancet Infectious Diseases"},{"key":"58_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0010-7824(97)00176-5","volume":"56","author":"CJ Elias","year":"1997","unstructured":"Elias CJ, Coggins C, Alvarez F, Brache V, Fraser IS, Lacarra M, Lahteenmaki P, Massai R, Mishell DR, Phillips DM, Salvatierra AM: Colposcopic evaluation of a vaginal gel formulation of iota-carrageenan. Contraception. 1997, 56: 387-389. 10.1016\/S0010-7824(97)00176-5.","journal-title":"Contraception"},{"key":"58_CR9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.contraception.2004.04.010","volume":"70","author":"CK Mauck","year":"2000","unstructured":"Mauck CK, Weiner DH, Creinin MD, Barnhart KT, Callahan MM, Bax R: A randomized phase 1 vaginal safety study of three concentrations of C31G vs. extra strength Gynol II. Contraception. 2000, 70: 233-240. 10.1016\/j.contraception.2004.04.010.","journal-title":"Contraception"},{"key":"58_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1086\/318496","volume":"31","author":"KH Mayer","year":"2001","unstructured":"Mayer KH, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z: Safety and Tolerability of Buffergel, a Novel Vaginal Microbicide, in Women in the United States. Clin Infect Dis. 2001, 31: 476-482. 10.1086\/318496.","journal-title":"Clin Infect Dis"},{"key":"58_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1097\/00126334-200101010-00003","volume":"26","author":"J Van de Wijgert","year":"2001","unstructured":"Van de Wijgert J, Fullem A, Kelly C, Mehendale S, Rogpao S, Kumwenda N, Chirenje Z, Joshi S, Taha T, Padian N, Bollinger R, Nelson K: Phase 1 trial of the Topical Microbicide BufferGel: Safety Results from Four International Sites. J Acquir Immune Defic Syndr. 2001, 26: 21-27.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"58_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00002030-200302140-00005","volume":"17","author":"KH Mayer","year":"2003","unstructured":"Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, for the HIV Prevention Trials Network (HPTN) 020 Protocol Team: Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 2003, 17: 321-329. 10.1097\/00002030-200302140-00005.","journal-title":"AIDS"},{"key":"58_CR13","unstructured":"Council for International Organizations of Medical Sciences (CIOMS) 1993 International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva."},{"key":"58_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/01.aids.0000210608.70762.c3","volume":"20","author":"KH Mayer","year":"2006","unstructured":"Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Rooney JF, Soto-Torres L and the HPTN 050 Protocol Team: Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006, 20: 543-551. 10.1097\/01.aids.0000210608.70762.c3.","journal-title":"AIDS"},{"key":"58_CR15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2307\/2991897","volume":"25","author":"JH Van de Wijgert","year":"1999","unstructured":"Van de Wijgert JH, Khumalo-Sakutukwa GN, Cogins C, Dube SE, Nyamapfeni P, Padian N: Men's attitudes toward vaginal microbicides and microbicide trials in Zimbabwe. International Family Planning Perspectives. 1999, 25: 15-20. 10.2307\/2991897.","journal-title":"International Family Planning Perspectives"},{"issue":"4","key":"58_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2307\/2673851","volume":"27","author":"G Ramgee","year":"2001","unstructured":"Ramgee G, Gouws E, Andrews A, Myer L, Weber AE: The Acceptability of a Vaginal Microbicide Among South African Men. International Family PlanningPerspectives. 2001, 27 (4): 164-170. 10.2307\/2673851.","journal-title":"International Family PlanningPerspectives"},{"key":"58_CR17","volume-title":"Conference Proceedings Microbicides","author":"D Onwujekwe","year":"2006","unstructured":"Onwujekwe D, Odunukwe N, Njemanze O, Ezeobi P, Gbajabiamila T, Adu R, Akinbami B, Audu R, Idigbe O: Acceptability of vaginal microbicide among Nigerian serodiscordant couples with female negative partner. Conference Proceedings Microbicides. 2006, Conference Cape Town South Africa 23\u201326 April 2006"},{"key":"58_CR18","volume-title":"Conference Proceedings Microbicides","author":"M Mzimela","year":"2006","unstructured":"Mzimela M: Acceptability of using a vaginal gel before sex in Umkanyakude District of KwaZulu Natal. Conference Proceedings Microbicides. 2006, Conference Cape Town South Africa 23\u201326 April 2006"},{"key":"58_CR19","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.socscimed.2006.02.019","volume":"63","author":"P Orner","year":"2006","unstructured":"Orner P, Harries J, Cooper D, Moodley J, Hoffman M, Becker J, McGrory E, Dabash R, Bracken H: Challenges to microbicide introduction in South Africa. Social Science and Medicine. 2006, 63: 968-978. 10.1016\/j.socscimed.2006.02.019.","journal-title":"Social Science and Medicine"},{"key":"58_CR20","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/S0277-9536(00)00162-3","volume":"52","author":"G Green","year":"2001","unstructured":"Green G, Pool R, Harrison S, Hart GJ, Wilkinson J, Nyanzi S, Whitworth JAG: Female control of sexuality: Illusion or reality? Use of vaginal products in southwest Uganda. Social Science and Medicine. 2001, 52: 585-598. 10.1016\/S0277-9536(00)00162-3.","journal-title":"Social Science and Medicine"},{"key":"58_CR21","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1097\/00002030-199811000-00022","volume":"12","author":"C Coggins","year":"1998","unstructured":"Coggins C, Elias C, Atisook R, Basset MT, Ettiegne-Traore V, Ghys PD, Jenkins-Woelk L, Thongkrajai E, Van Devanter NL: A study of women's preferences regarding the formulation of over-the-counter vaginal spermicides. AIDS. 1998, 12: 1389-1391. 10.1097\/00002030-199811000-00022.","journal-title":"AIDS"},{"key":"58_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2307\/2991552","volume":"31","author":"JE Darroch","year":"1999","unstructured":"Darroch JE, Frost J: Women's interest in vaginal microbicides. Family Planning Perspectives. 1999, 31: 16-23. 10.2307\/2991552.","journal-title":"Family Planning Perspectives"},{"key":"58_CR23","volume-title":"Conference Proceedings Microbicides","author":"S Hofman","year":"2006","unstructured":"Hofman S: Covert Use of a Vaginal Microbicide: Views of Women Participating in a Phase 1 Trial of Tenofovir Gel (HPTN 050). Conference Proceedings Microbicides. 2006, Conference Cape Town South Africa 23\u201326 April 2006"},{"key":"58_CR24","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1136\/sti.2006.019794","volume":"82","author":"M Schwandt","year":"2006","unstructured":"Schwandt M, Morris C, Ferguson A, Ngugi , Moses S: Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sexually Transmitted Infections. 2006, 82: 392-396. 10.1136\/sti.2006.019794.","journal-title":"Sexually Transmitted Infections"},{"key":"58_CR25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.2105\/AJPH.88.4.571","volume":"88","author":"I De Zoysa","year":"1998","unstructured":"De Zoysa I, Elias CJ, Bentley ME: Ethical challenges in efficacy trials of vaginal microbicides for HIV prevention. Am J Public Health. 1998, 88: 571-575.","journal-title":"Am J Public Health"},{"key":"58_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/00002030-200102001-00075","volume":"15","author":"M Potts","year":"2001","unstructured":"Potts M: The ethics of testing microbicides: are we protecting the volunteers or the investigators?. AIDS. 2001, 15: 49-53. 10.1097\/00002030-200102001-00075.","journal-title":"AIDS"},{"key":"58_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/jme.2004.008102","volume":"31","author":"K Shapiro","year":"2005","unstructured":"Shapiro K, Benatar SR: HIV prevention and global inequality: steps toward improved standards of care. J Med Ethics. 2005, 31: 39-49. 10.1136\/jme.2004.008102.","journal-title":"J Med Ethics"},{"key":"58_CR28","volume-title":"Conference Proceedings HPTN Microbicide Safety Consensus Meeting, Bethesda, 1\u20133","author":"D Birnkrant","year":"2006","unstructured":"Birnkrant D: Safety Considerations in Microbicide Trials: FDA Perspective. Conference Proceedings HPTN Microbicide Safety Consensus Meeting, Bethesda, 1\u20133. 2006, March"},{"key":"58_CR29","unstructured":"World Health Organisation (WHO) Scientific and Ethical Review Group: Guidelines on reproductive heath research and partners'agreement."},{"key":"58_CR30","volume-title":"Conference Proceedings Microbicides","author":"E Tolley","year":"2006","unstructured":"Tolley E: Ethical issues related to pregnancy during microbicide trials. Conference Proceedings Microbicides. 2006, Conference Cape Town South Africa 23\u201326 April 2006"},{"key":"58_CR31","unstructured":"Smart T: Microbicides 2006: High rates of pregnancy pose challenges for microbicide trials. [\n                    http:\/\/www.aidsmap.com\/en\/news\/3F76DCE3-83FA-4523-A920-5CB0829DD33A.asp\n                    \n                  ]"},{"key":"58_CR32","volume-title":"Microbicides 2006 Conference, Cape Town, OB15","author":"E Raymond","year":"2006","unstructured":"Raymond E: Issues related to pregnancies in microbicide effectiveness trials. Microbicides 2006 Conference, Cape Town, OB15. 2006"},{"key":"58_CR33","volume-title":"Microbicides 2006 Conference, Cape Town, OB17","author":"W Rountree","year":"2006","unstructured":"Rountree W: Change in sexual behavior post-pregnancy in the Savvy Ghana trial. Microbicides 2006 Conference, Cape Town, OB17. 2006"},{"key":"58_CR34","volume-title":"Microbicides 2006 Conference, Cape Town, PB67","author":"CA Schreiber","year":"2006","unstructured":"Schreiber CA: The impact of pregnancy on microbicide clinical trials. Microbicides 2006 Conference, Cape Town, PB67. 2006"},{"issue":"4","key":"58_CR35","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2105\/AJPH.88.4.637","volume":"88","author":"Q Abdool Karim","year":"1998","unstructured":"Abdool Karim Q, Abdool Karim SS, Coovadia HM, Susser M: Informed Consent for HIV Testing in a South African Hospital: Is It Truly Informed and Truly Voluntary?. American J of Public Health. 1998, 88 (4): 637-40.","journal-title":"American J of Public Health"},{"issue":"4","key":"58_CR36","doi-asserted-by":"publisher","first-page":"582","DOI":"10.2105\/AJPH.93.4.582","volume":"93","author":"G Joubert","year":"2003","unstructured":"Joubert G, Steinberg H, van der Ryst E, Chikobvu P: Consent for Participation in the Bloemfontein Vitamin a Trial: How Informed and Voluntary?. American J of Public Health. 2003, 93 (4): 582-84.","journal-title":"American J of Public Health"},{"key":"58_CR37","first-page":"727","volume":"31","author":"K Moodley","year":"2005","unstructured":"Moodley K, Pather M, Myer L: Informed Consent: Participants' Knowledge and Perceptions of Influenza Vaccine Trial Involvement in South Africa. JME. 2005, 31: 727-732.","journal-title":"JME"},{"key":"58_CR38","volume-title":"Child Care Act No 74 of","author":"South African Parliament","year":"1983","unstructured":"South African Parliament: Child Care Act No 74 of. 1983"},{"key":"58_CR39","volume-title":"Children's Act No 38 of","author":"South African Parliament","year":"2005","unstructured":"South African Parliament: Children's Act No 38 of. 2005"},{"key":"58_CR40","volume-title":"National Health Act No 61 of","author":"South African Parliament","year":"2003","unstructured":"South African Parliament: National Health Act No 61 of. 2003"},{"key":"58_CR41","volume-title":"Sunday Times","author":"P Govender","year":"2005","unstructured":"Govender P: Girls bunk school to cash in on HIV trials. Sunday Times. 2005"}],"container-title":["BMC Medical Ethics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6939-8-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-8-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-8-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6939-8-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T12:14:42Z","timestamp":1548159282000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedethics.biomedcentral.com\/articles\/10.1186\/1472-6939-8-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,19]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1186\/1472-6939-8-10","relation":{},"ISSN":["1472-6939"],"issn-type":[{"value":"1472-6939","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,19]]},"article-number":"10"}}